导管原位癌情况下的乳腺磁共振成像：仍需进行高质量试验以确定其价值。
Breast MRI in the setting of DCIS: quality trials are still needed to determine its value.
作者信息
Rahbar Habib, Tjoe Judy A
机构信息
Department of Radiology, University of Washington School of Medicine, Seattle Cancer Care Alliance, 1144 Eastlake Ave East Rm LG-200, Seattle, WA, 98109, USA.
Department of Breast Surgery, Novant Health Surgical Institute, 3515 West Market Street, Suite 300, Greensboro, NC, 27403, USA.
出版信息
Eur Radiol. 2021 Aug;31(8):5877-5879. doi: 10.1007/s00330-021-08057-8. Epub 2021 May 28.
• Existing evidence suggests that preoperative breast MRI does not improve treatment outcomes for DCIS. • The quality of the available data used to answer this question is poor. • Quality randomized controlled trials are needed to definitively assess the benefits and harms of preoperative MRI in the setting of DCIS.
• 现有证据表明，术前乳腺磁共振成像（MRI）并不能改善导管原位癌（DCIS）的治疗效果。
• 用于回答这个问题的现有数据质量较差。
• 需要高质量的随机对照试验来明确评估DCIS情况下术前MRI的益处和危害。
Zotero 插件